Proyectos de ley › 89.ª Asamblea General

HF 514Firmado por gobernador(a) · 30 de abril de 2021

Relating to the practice of pharmacy, and providing for a repeal

Presentado por el comité Human Resources de la Cámara

Temas:Health care

La misma legislación: HSB 73, SSB 1111, SF 416

Dónde está ahora

  1. Hecho: Presentado15 de febrero de 2021
  2. Se saltó: SubcomitéSe saltó
  3. Hecho: Comité de la Cámara23 de febrero de 2021
  4. Hecho: Lo aprueba la Cámara23 de febrero de 2021
  5. Hecho: Comité del Senado1 de abril de 2021
  6. Hecho: Lo aprueba el Senado7 de abril de 202144–0
  7. Hecho: A gobernador(a)30 de abril de 2021
  8. Hecho: Firmado como ley30 de abril de 2021

Firmado como ley ¿Qué es el embudo (funnel)?

Qué contiene

La explicación oficial está en inglés; todavía no hay resumen en palabras sencillas.

This bill relates to pharmacy practice. Division I of the bill eliminates the tech-check-tech program.33A. Division I eliminates the one-year registration limitation for a person in training to become a pharmacy technician and makes conforming terminology changes. Division I also amends provisions relating to the delegation of technical functions between a pharmacist and a pharmacy technician or pharmacy support person. Division II of the bill requires a drug compounding outsourcing facility seeking licensure in the state to have been inspected by the facility’s home state regulatory authority or other entity approved by the board in the two-year period immediately preceding the application, which inspection demonstrates compliance with federal current good manufacturing practices.

Lea la explicación completa

Division II also allows the board to recover from an outsourcing facility costs associated with conducting an inspection to satisfy the inspection requirement. Division III of the bill authorizes the board of pharmacy to share information collected relating to compounded human drug products with the United States food and drug administration (FDA) pursuant to any memorandum of understanding between the board of pharmacy and the FDA. Division IV of the bill codifies the provisions of 2011 Iowa Acts, chapter 63, section 36, relating to pharmacy pilot or demonstration research projects. The language in Division IV differs from these provisions by eliminating language limiting the projects to those based solely on prescription verification and by eliminating the requirement that the board report the approval or denial of projects to the chairpersons and ranking members of the joint appropriations subcommittee on health and human services.

Texto completo del proyecto (en inglés) · Qué cambió antes de aprobarse1

Lo que cambia del Código de Iowa (Iowa Code)

Crea§155A.47

Modifica§147.107§155A.13C§155A.3§155A.33§155A.45§155A.6A

Cómo funciona el Código2

Cabildeo

5 a favor · 1 en contra · 15 indecisos · Quiénes →

Family tree

Earlier and later bills are matched by wording or an identical title.

Tried before

This idea has been filed in an earlier General Assembly. None got through a chamber.

  • HF 2507 Relating to the practice of pharmacy, and providing for a repeal
    88th General Assembly · Approved by committee · same title
    Cleared committee

Matched by wording or an identical title.